ClinVar Miner

Submissions for variant NM_001378328.1(CELSR1):c.1210G>A (p.Glu404Lys)

gnomAD frequency: 0.00031  dbSNP: rs201107590
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001267723 SCV001445978 uncertain significance Walker-Warburg congenital muscular dystrophy 2020-11-16 criteria provided, single submitter curation The heterozygous p.Glu404Lys variant in CELSR1 was identified by our study in the compound heterozygous state, along with a variant of unknown significance, in 1 individual with suspected Walker-Warburg syndrome. The variant has not been previously reported in individuals with Walker-Warburg syndrome but has been identified in 0.04% (55/126242) of European non-Finnish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs201107590). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools, including splice predictors, and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. Finally, although this gene has been reported in association with Walker-Warburg syndrome, it currently has limited evidence for these associations. In summary, while the clinical significance of the p.Glu404Lys variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: BP4 (Richards 2015).
Ambry Genetics RCV004035430 SCV004922605 uncertain significance not specified 2023-12-26 criteria provided, single submitter clinical testing The c.1210G>A (p.E404K) alteration is located in exon 1 (coding exon 1) of the CELSR1 gene. This alteration results from a G to A substitution at nucleotide position 1210, causing the glutamic acid (E) at amino acid position 404 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.